Stratec SE (ETR:SBS – Get Free Report)’s share price traded up 1.4% during trading on Tuesday . The company traded as high as €18.48 and last traded at €18.46. 3,704 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 6,253 shares. The stock had previously closed at €18.20.
Stratec Stock Performance
The firm has a 50 day moving average of €17.51 and a two-hundred day moving average of €19.46. The stock has a market cap of $221.77 million, a P/E ratio of 22.15, a P/E/G ratio of 10.43 and a beta of 0.80. The company has a debt-to-equity ratio of 49.40, a quick ratio of 1.65 and a current ratio of 4.33.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Featured Articles
- Five stocks we like better than Stratec
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
